Simone Pinton Selected Research

Simone Pinton Research Topics

Disease

5	Dementia (Dementias) 01/2013 - 03/2010
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2013
4	Cognitive Dysfunction 04/2021 - 04/2011
3	Neuroinflammatory Diseases 12/2019 - 01/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2019 - 03/2013
3	Body Weight (Weight, Body) 05/2018 - 05/2011
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021 - 04/2017
2	Parkinson Disease (Parkinson's Disease) 04/2017 - 01/2017
2	Gliosis 01/2014 - 01/2013
2	Infections 09/2013 - 01/2012
2	Memory Disorders (Memory Loss) 06/2013 - 04/2012
1	Teratogenesis 04/2021
1	Hypertension (High Blood Pressure) 10/2020
1	Hyperglycemia 01/2019
1	Hemolysis 05/2017
1	Hyperlipidemias (Hyperlipidemia) 06/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Amyloidosis 01/2014
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014
1	Methylmalonic acidemia 09/2013
1	Seizures (Absence Seizure) 03/2013
1	Inflammation (Inflammations) 01/2013
1	Mania (Manias) 08/2012
1	Renal Insufficiency (Renal Failure) 05/2011

Drug/Important Bio-Agent (IBA)

5	p-methoxy-diphenyl diselenideIBA 06/2013 - 03/2010
5	p,p'-methoxyl-diphenyl diselenideIBA 06/2013 - 03/2010
5	Streptozocin (Streptozotocin)FDA Link 01/2013 - 03/2010
4	diphenyldiselenideIBA 05/2018 - 05/2011
3	AntioxidantsIBA 01/2022 - 04/2011
3	Neuroprotective AgentsIBA 04/2021 - 03/2010
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2016
2	AcetylcholinesteraseIBA 01/2022 - 01/2014
2	LipidsIBA 04/2021 - 05/2011
2	NanocapsulesIBA 04/2021 - 04/2021
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2021 - 10/2020
2	CurcuminIBA 04/2021 - 04/2021
2	CholesterolIBA 09/2019 - 01/2014
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2017 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2014 - 06/2013
2	Peptides (Polypeptides)IBA 01/2014 - 04/2012
2	Therapeutic UsesIBA 06/2013 - 01/2013
1	Chelating AgentsIBA 01/2022
1	MetalsIBA 01/2022
1	Meloxicam (Mobic)FDA LinkGeneric 04/2021
1	Amyloid beta-PeptidesIBA 04/2021
1	CadmiumIBA 10/2020
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2020
1	7-chloro-4-(phenylselanyl) quinolineIBA 09/2019
1	Cholinergic Agents (Cholinergics)IBA 09/2019
1	Liver GlycogenIBA 01/2019
1	Malathion (Karbofos)FDA LinkGeneric 01/2019
1	indolin-2-oneIBA 01/2019
1	(3Z)- 5- Chloro- 3- (hydroxyimino)indolin- 2- oneIBA 01/2019
1	AcidsIBA 05/2017
1	Nerve Growth Factors (Neurotrophins)IBA 04/2017
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2017
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2017
1	antineoplaston A10 (A 10)IBA 06/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016
1	JNK Mitogen-Activated Protein KinasesIBA 01/2016
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2014
1	LDL Receptors (LDL Receptor)IBA 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	oxidized low density lipoproteinIBA 01/2014
1	Methylmalonic AcidIBA 09/2013
1	Inflammation MediatorsIBA 09/2013
1	Pentylenetetrazole (Metrazol)IBA 03/2013
1	thiobarbituric acidIBA 03/2013
1	CreatineIBA 03/2013
1	SeleniumIBA 01/2013
1	ATPase Inhibitory ProteinIBA 08/2012
1	Ouabain (G Strophanthin)IBA 08/2012
1	Hormones (Hormone)IBA 02/2012
1	SolutionsIBA 01/2012
1	Glycerol (Glycerine)FDA LinkGeneric 05/2011
1	Urea (Carbamide)FDA LinkGeneric 05/2011
1	CreatinineIBA 05/2011

Therapy/Procedure

1	Intraventricular Infusions 06/2013